Guggenheim lowered the firm’s price target on Argenx (ARGX) to $1,065 from $1,100 and keeps a Buy rating on the shares. Argenx continues to deliver solid performance with results that “underscore the strength of its fundamentals,” says the analyst, who views weakness in the shares as “an especially compelling buying opportunity” given the robust pipeline and long-term growth drivers.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARGX:
- Buy Recommendation for Argenx: Strong Vyvgart Sales Growth and Promising PFS Launch Drive Confidence
- Argenx price target raised to $803 from $796 at Citi
- Argenx Reports Strong Q1 2025 Financial Performance
- Argenx Se: Strong Sales and Financial Performance Reinforce Buy Rating Amid Stock Selloff
- Strong Buy Rating for Argenx Amid Vyvgart’s Outperformance and Promising Pipeline
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue